Fund Holdings — Boxer Capital Management, LLC

Total Portfolio Value:
$1.15B
Total Bought:
$159.56M
Total Sold:
$448.97M
Net Transaction:
-$289.41M
Notable People:
Aaron Isaac Davis
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Tango Therapeutics, Inc.(TNGX)10,876,21910,526,219-350,000$339.99M$262.63M22.82%-$77.36M
Kodiak Sciences Inc.(KOD)1,477,6001,477,6000$57.57M$140.08M12.17%+$82.51M
Revolution Medicines, Inc.(RVMD)500,000500,0000$93.64M$102.63M8.92%+$8.99M
Kymera Therapeutics, Inc.(KYMR)429,100524,551+95,451$49.20M$58.64M5.10%+$9.43M
Replimune Group, Inc.(REPL)3,983,0004,278,159+295,159$44.09M$56.64M4.92%+$12.55M
ABIVAX Société AnonymeADS(ABVX)605,000474,971-130,029$80.62M$47.03M4.09%-$33.59M
Surrozen Inc1,105,6831,360,683+255,000$26.96M$43.79M3.81%+$16.82M
Corcept Therapeutics Incorporated(CORT)335,500335,5000$29.17M$38.66M3.36%+$9.49M
Precigen, Inc.(PGEN)5,150,0004,320,339-829,661$29.36M$36.98M3.21%+$7.63M
uniQure N.V.SHS(QURE)1,503,3001,423,243-80,057$69.24M$34.39M2.99%-$34.86M
Definium Therapeutics, Inc.(DFTX)998,500683,615-314,885$46.97M$26.02M2.26%-$20.95M
Amylyx Pharmaceuticals, Inc.(AMLX)800,000893,153+93,153$14.37M$25.99M2.26%+$11.62M
Spyre Therapeutics, Inc.(SYRE)100,000283,054+183,054$8.88M$25.20M2.19%+$16.32M
Protagonist Therapeutics Inc170,000170,0000$20.84M$23.95M2.08%+$3.11M
Celcuity Inc.(CELC)416,530286,239-130,291$43.58M$22.76M1.98%-$20.82M
Opus Genetics Inc2,815,0004,533,660+1,718,660$11.57M$21.94M1.91%+$10.37M
Q32 Bio Inc3,149,3102,577,642-571,668$40.12M$21.32M1.85%-$18.81M
UroGen Pharma Ltd.(URGN)500,000500,0000$18.40M$20.32M1.77%+$1.92M
Achieve Life Science Inc02,150,000+2,150,000$0$17.39M1.51%+$17.39M
C4 Therapeutics Inc04,150,000+4,150,000$0$13.82M1.20%+$13.82M
First Tracks Biotherapeutics0240,000+240,000$0$8.51M0.74%+$8.51M
Shattuck Labs Inc1,000,0001,175,396+175,396$6.94M$8.02M0.70%+$1.08M
Sab Biotherapeutics Inc02,500,000+2,500,000$0$7.92M0.69%+$7.92M
Cullinan Therapeutics Inc0450,000+450,000$0$6.91M0.60%+$6.91M
Contineum Therapeutics IncCL A494,000494,0000$8.10M$6.63M0.58%-$1.47M
Cytokinetics, Incorporated(CYTK)100,000100,0000$8.52M$6.59M0.57%-$1.93M
Palisade Bio Inc4,799,8754,799,8750$10.03M$6.48M0.56%-$3.55M
Capricor Therapeutics Inc1,395,156642,837-752,319$33.60M$6.09M0.53%-$27.51M
Electra Therapeutics Inc0450,000+450,000$0$5.06M0.44%+$5.06M
An2 Therapeutics Inc749,035944,035+195,000$3.63M$5.02M0.44%+$1.40M
Maze Therapeutics, Inc.(MAZE)0175,465+175,465$0$4.77M0.41%+$4.77M
Edesa Biotech Inc205,000937,363+732,363$1.67M$3.95M0.34%+$2.28M
Relay Therapeutics, Inc.(RLAY)450,000200,000-250,000$8.42M$3.61M0.31%-$4.81M
Kazia Therapeutics LtdADS560,000371,500-188,500$7.88M$3.56M0.31%-$4.32M
Attovia Therapeutics Inc0200,000+200,000$0$3.43M0.30%+$3.43M
Pmv Pharmaceuticals Inc02,050,000+2,050,000$0$3.42M0.30%+$3.42M
Crescent Biopharma Inc.453,686226,843-226,843$8.17M$3.31M0.29%-$4.86M
Zentalis Pharmaceuticals Inc01,013,555+1,013,555$0$2.81M0.24%+$2.81M
Sarepta Therapeutics, Inc.(SRPT)150,000150,0000$2.70M$2.73M0.24%+$37.5K
Allogene Therapeutics Inc1,500,0001,500,0000$3.12M$2.40M0.21%-$720.0K
Nurix Therapeutics, Inc.(NRIX)100,000100,0000$2.43M$2.37M0.21%-$55.0K
Sionna Therapeutics Inc0391,723+391,723$0$2.06M0.18%+$2.06M
Clene Inc477,515477,5150$2.94M$1.95M0.17%-$990.8K
Aclaris Therapeutics Inc0300,000+300,000$0$1.58M0.14%+$1.58M
Milestone Pharmaceuticals In666,666666,6660$893.3K$577.1K0.05%-$316.2K
Neumora Therapeutics Inc.2,000,000954,052-1,045,948$3.40M$568.8K0.05%-$2.83M
Karyopharm Therapeutics Inc302,536127,536-175,000$2.96M$155.6K0.01%-$2.80M
Apogee Therapeutics Inc70,0000-70,000$9.29M$0—-$9.29M
Avalo Therapeutics, Inc.(AVTX)375,0000-375,000$6.93M$0—-$6.93M
Cogent Biosciences, Inc.(COGT)225,0000-225,000$8.71M$0—-$8.71M
Corvus Pharmaceuticals, Inc.(CRVS)1,100,0000-1,100,000$16.43M$0—-$16.43M
Cybin D/B/A Helus Pharma(HELP)790,0000-790,000$5.22M$0—-$5.22M
Faeth Therapeutics, Inc.(FTH)180,5050-180,505$4.51M$0—-$4.51M
Forte Biosciences Inc274,5000-274,500$5.83M$0—-$5.83M
Immatics N.V.SHS(IMTX)475,0000-475,000$4.81M$0—-$4.81M
Inovio Pharmaceuticals, Inc.(INO)2,844,9940-2,844,994$3.13M$0—-$3.13M
Invivyd, Inc.(IVVD)1,500,0000-1,500,000$1.31M$0—-$1.31M
LB Pharmaceuticals Inc(LBRX)70,0000-70,000$2.27M$0—-$2.27M
MapLight Therapeutics, Inc.(MPLT)75,0000-75,000$2.69M$0—-$2.69M
MoonLake ImmunotherapeuticsCL A(MLTX)275,0000-275,000$5.35M$0—-$5.35M
Ocular Therapeutix, Inc.(OCUL)1,300,0000-1,300,000$12.77M$0—-$12.77M
Odyssey Therapeutics Inc275,0000-275,000$5.15M$0—-$5.15M
ORIC Pharmaceuticals, Inc.(ORIC)350,0000-350,000$3.79M$0—-$3.79M
PepGen Inc.(PEPG)272,8920-272,892$491.2K$0—-$491.2K
Praxis Precision Medicines, Inc.(PRAX)46,4570-46,457$15.55M$0—-$15.55M
PTC Therapeutics, Inc.(PTCT)200,0000-200,000$16.31M$0—-$16.31M
REGENXBIO Inc.(RGNX)15,0000-15,000$179.7K$0—-$179.7K
Relmada Therapeutics, Inc.(RLMD)842,1060-842,106$5.83M$0—-$5.83M
Solid Biosciences Inc300,0000-300,000$3.00M$0—-$3.00M
Structure Therapeutics IncADS75,0000-75,000$4.03M$0—-$4.03M
Surrozen, Inc.W EXP 08 01 203(SRZN)66,6660-66,666$1.1K$0—-$1.1K
Upstream Bio, Inc.(UPB)150,0000-150,000$1.04M$0—-$1.04M
Vaxcyte, Inc.(PCVX)325,0000-325,000$18.89M$0—-$18.89M
Vir Biotechnology, Inc.(VIR)1,866,0000-1,866,000$19.01M$0—-$19.01M
Zura Bio LimitedCL A(ZURA)900,0000-900,000$5.31M$0—-$5.31M
Page 1 of 1
Boxer Capital Management, LLC — 13F Holdings — Q3 2026 | TickerTrail